BD launches portable, rapid point-of-care antigen test to detect SARS-CoV-2

BD Veritor™ Plus System
The simple new assay leverages more than 25,000 BD Veritor™ instruments already used across the U.S. to immediately increase access to COVID-19 testing in frontline health care settings Continue reading
Read More...

Becton Dickinson announces FDA Emergency Use Authorization for new COVID-19 diagnostic for use in U.S.

Becton Dickinson, a leading global medical technology company, and BioGX Inc., a molecular diagnostics company, announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for a new diagnostic test that will enable hospitals to screen for COVID-19 (coronavirus) on site and get results...
Read More...